Breast MRI Developments in Screening, Diagnosis & Treatment
Weekend Course
ORGANIZERS: Mami Iima, Sonal Krishan
Sunday, 11 May 2025
316B
13:15 -
15:15
Moderators: Bonnie Joe & Linda Moy
Skill Level: Basic to Advanced
Session Number: WE-32
No CME/CE Credit
Session Number: WE-32
Overview
Breast MRI has seen several important innovations in recent years that are improving cancer diagnosis and treatment planning. This session will cover advancements in abbreviated MRI protocols, ultrafast dynamic contrast-enhanced (DCE) MRI, diffusion-weighted imaging (DWI), artificial intelligence (AI) integration, multiparametric MRI, MRI-guided biopsies, treatment response monitoring, and preoperative staging. These innovations are expanding the role of breast MRI from a problem-solving tool to an integral part of breast cancer screening, diagnosis, and treatment planning.
Target Audience
Radiologists, MRI physicists, oncologistsl, and other healthcare professionals involved and interested in breast cancer diagnosis and treatment.
Educational Objectives
As a result of attending this course, participants should be able to:
• Evaluate the clinical impact and implementation strategies of abbreviated MRI protocols and ultrafast dynamic contrast-enhanced (DCE) MRI in breast cancer screening and diagnosis;
• Assess the role of diffusion-weighted imaging (DWI) and multiparametric MRI in improving the specificity and accuracy of breast lesion characterization; and
• Interpret the integration of artificial intelligence (AI) in breast MRI interpretation and its potential to enhance diagnostic accuracy and workflow efficiency.
| 13:15 | | Abbreviated MRI Protocols & Ultrafast Dynamic Contrast-Enhanced (DCE) MRI Masako Kataoka |
| 13:45 | | Diffusion-Weighted Imaging (DWI) & Multiparametric MRI Katja Pinker-Domenig Keywords: Body: Breast, Education Committee: Clinical MRI Breast MRI is the most sensitive modality for breast cancer detection with DCE MRI being its backbone. DWI is a non-contrast MRI technique that measures the diffusion of water molecules within biologic tissue and is increasingly incorporated into routine breast MRI. Main applications of multiparametric breast MRI including DWI are breast cancer detection, characterization, prognostication, assessment of treatment response to neoadjuvant chemotherapy and DWI alone might also be a non-contrast alternative for breast cancer screening. In this session, we present a summary of the implementation of DWI & Multiparametric MRI in clinical practice, discuss challenges, technical advances and future directions |
| 14:15 | | AI Integration in Breast MRI: Enhancing Diagnostic Accuracy Simone Schiaffino |
| 14:45 | | MRI for Treatment Monitoring in Breast Cancer: Clinical Applications & Challenges Eun Sook Ko Keywords: Body: Breast This talk explores key clinical considerations in evaluating neoadjuvant chemotherapy (NAC) response and the challenges of using MRI in this setting. Conventional MRI features, including lesion morphology, enhancement patterns, and shrinkage patterns, play a crucial role in assessing treatment response and predicting pathologic complete response (pCR) or survival. However, MRI accuracy is influenced by tumor subtype and histologic characteristics, which may impact response evaluation. Additionally, this talk will discuss the challenges of MRI in NAC setting and the potential role of emerging techniques such as diffusion-weighted imaging (DWI), ultrafast imaging and radiomics. |